GE HealthCare Technologies (NASDAQ:GEHC – Free Report) had its target price cut by BNP Paribas Exane from $95.00 to $88.00 in a research report report published on Friday morning,MarketScreener reports.
A number of other analysts also recently weighed in on GEHC. Bank of America boosted their target price on shares of GE HealthCare Technologies from $82.00 to $92.00 and gave the stock a “neutral” rating in a report on Monday, January 5th. Evercore set a $80.00 target price on GE HealthCare Technologies in a report on Thursday. Stifel Nicolaus set a $80.00 target price on GE HealthCare Technologies in a report on Wednesday. Oppenheimer restated an “outperform” rating and set a $85.00 target price on shares of GE HealthCare Technologies in a report on Thursday. Finally, Barclays lowered their target price on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating for the company in a report on Thursday. Eight analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $82.00.
View Our Latest Research Report on GE HealthCare Technologies
GE HealthCare Technologies Price Performance
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. During the same quarter last year, the firm earned $1.01 earnings per share. The business’s quarterly revenue was up 7.4% on a year-over-year basis. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts predict that GE HealthCare Technologies will post 4.88 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 3.35%.
Insider Activity at GE HealthCare Technologies
In other news, insider Frank R. Jimenez bought 1,750 shares of the firm’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average price of $60.45 per share, with a total value of $105,787.50. Following the completion of the transaction, the insider directly owned 93,932 shares of the company’s stock, valued at approximately $5,678,189.40. The trade was a 1.90% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO James Saccaro bought 3,310 shares of the firm’s stock in a transaction that occurred on Friday, May 1st. The shares were purchased at an average cost of $60.60 per share, with a total value of $200,586.00. Following the transaction, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at $5,300,742.60. The trade was a 3.93% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders bought 9,229 shares of company stock valued at $556,180 over the last 90 days. Insiders own 0.36% of the company’s stock.
Institutional Investors Weigh In On GE HealthCare Technologies
A number of hedge funds and other institutional investors have recently bought and sold shares of GEHC. E Fund Management Hong Kong Co. Ltd. lifted its position in GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after acquiring an additional 196 shares during the last quarter. Godsey & Gibb Inc. purchased a new stake in GE HealthCare Technologies during the third quarter valued at approximately $26,000. Laurel Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies during the fourth quarter valued at approximately $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the fourth quarter worth $27,000. Finally, Godfrey Financial Associates Inc. purchased a new position in shares of GE HealthCare Technologies in the fourth quarter worth $27,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.
GE HealthCare Technologies Company Profile
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Stories
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
